Group 1 - The company Zhongju High-tech announced a share buyback plan, intending to use between RMB 300 million and RMB 600 million of its own and/or self-raised funds to repurchase shares at a price not exceeding RMB 26 per share [1] - The buyback is aimed at canceling shares and reducing the company's registered capital, pending approval at the first extraordinary shareholders' meeting in 2026 [1] - As of January 13, 2026, the top ten unrestricted shareholders hold approximately 296 million shares, accounting for 38.44% of the total shares [1] Group 2 - The article discusses the peculiar situation of Haili Biological, which saw a ninefold increase in valuation through acquisitions, yet its valuation halved within eight months [2] - Notably, the company's largest client is a company that has not yet been established, highlighting unusual circumstances surrounding its business operations [2]
中炬高新:截至2026年1月13日前十大流通股东持股占比38.44%